fullscreen

eFinder

eFinder

Home › Article

CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash

Nbcwashington · 🇺🇸 public United States · · 311 words · By Berkeley Lovelace Jr; NBC News
headphones Listen to the eFinder podcast briefing
Ready to play
Daily briefing

What to know about CVS Caremark will cover Lilly’s weight loss drug Zepbound again after patient backlash

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday.

Claims checked 9
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center100%
Right0%

4 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday.

Why it matters

CVS Caremark is one of the country’s largest pharmacy benefit managers, deciding which medications millions of people in the U.S.

Common ground

can get through insurance and how much they pay out of pocket.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://www.nbcwashington.com/news/national-international/cvs-caremark-will-cove…

fact_checkClaims Checked

eFinder analyzed this article and checked 9 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

check_circle Corroborated 5
info Single Source 2
verified Verified By Reference 1
help Insufficient Evidence 1
check_circle
Claim 1: “CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year”
CORROBORATED
Multiple independent web sources confirm that CVS Caremark will resume coverage of Zepbound after previously removing it from its formulary.
travel_explore
web search NEUTRAL — May 28, 2026 · Zepbound will return to CVS Caremark's formulary by Oct. 1 and that some patients with private insurance could pay as little as a $25 copay.
https://www.yahoo.com/news/us/articles/cvs-caremark-cover-li…
travel_explore
web search NEUTRAL — Zepbound will return to CVS Caremark's formulary by Oct. 1 and that some patients with private insurance could pay as little as a $25 copay.
https://www.aol.com/articles/cvs-caremark-cover-lilly-weight…
travel_explore
web search NEUTRAL — May 28, 2026 · Zepbound will return to CVS Caremark's formulary by Oct. 1 and that some patients with private insurance could pay as little as a $25 copay.
https://www.nbcnews.com/health/health-news/cvs-caremark-will…
check_circle
Claim 2: “Zepbound has a monthly list price of $1,086”
CORROBORATED
Multiple sources, including CNBC and cost guides, cite the list price of Zepbound as approximately $1,086 per month.
menu_book
wikipedia NEUTRAL — Tirzepatide is a gastric inhibitory polypeptide (GIP) analog and a GLP-1 receptor agonist. It is used as an antidiabetic medication to treat type 2 diabetes and for weight loss. Tirzepatide is adminis…
https://en.wikipedia.org/wiki/Tirzepatide
menu_book
wikipedia NEUTRAL — Anat Ashkenazi (Hebrew: ענת אשכנזי) is an Israeli-American business executive and is current chief financial officer of Alphabet Inc. and its subsidiary Google. She had previously worked at Eli Lilly…
https://en.wikipedia.org/wiki/Anat_Ashkenazi
menu_book
wikipedia NEUTRAL — Roman Health Ventures Inc., doing business as Ro, is an American telehealth company that diagnoses patients, and subsequently prescribes and delivers treatments and ongoing care. The company is headqu…
https://en.wikipedia.org/wiki/Ro_(company)
+ 3 more evidence sources
check_circle
Claim 3: “Foundayo, Lilly’s weight loss pill that was approved in April, will also be added to the list starting Monday.”
CORROBORATED
Multiple sources confirm that Foundayo, a weight loss pill approved in April, will be added to the CVS Caremark formulary starting Monday.
travel_explore
web search NEUTRAL — CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year.Foundayo, Lilly’s weight loss pill that was approved in Apr…
https://www.nbcphiladelphia.com/news/national-international/…
travel_explore
web search NEUTRAL — Foundayo — Lilly’s New Weight Loss Pill — Is Also Being Added to CVS Caremark. Foundayo, Lilly’s weight loss pill that was approved in April 2026, will also be added to the CVS Caremark formulary star…
https://allaboutlawyer.com/cvs-caremark-zepbound-coverage-re…
travel_explore
web search NEUTRAL — CVS Health's pharmacy benefit management unit, CVS Caremark, announced Thursday that it will restore coverage of Eli Lilly's weight loss injection Zepbound and add the company's new oral weight loss p…
https://finance.yahoo.com/sectors/healthcare/articles/cvs-ca…
verified
Claim 4: “CVS Caremark is one of the country’s largest pharmacy benefit managers”
VERIFIED BY REFERENCE
Wikipedia and multiple other sources explicitly state that CVS Caremark is one of the largest pharmacy benefit managers in the US.
menu_book
wikipedia NEUTRAL — CVS Caremark Corporation is the pharmacy benefit management subsidiary of CVS Health Corporation, headquartered in Woonsocket, Rhode Island. As a pharmacy benefit manager (PBM), CVS Caremark handles p…
https://en.wikipedia.org/wiki/CVS_Caremark
menu_book
wikipedia NEUTRAL — CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provide…
https://en.wikipedia.org/wiki/CVS_Health
menu_book
wikipedia NEUTRAL — CVS Pharmacy Inc. is an American retail corporation. A subsidiary of CVS Health, it is headquartered in Woonsocket, Rhode Island. Originally named the Consumer Value Stores, it was founded in Lowell, …
https://en.wikipedia.org/wiki/CVS_Pharmacy
+ 4 more evidence sources
info
Claim 5: “The move did not affect patients taking Lilly’s diabetes drug Mounjaro, which contains the same active ingredient as Zepbound.”
SINGLE SOURCE
While evidence confirms Zepbound was removed and is returning, none of the provided evidence snippets explicitly mention whether Mounjaro was unaffected by this specific move.
travel_explore
web search NEUTRAL — As of June 2025, CVS Caremark has removed Zepbound from its formulary for certain plans, potentially affecting coverage for members. This change takes effect July 1, 2025, and impacts only select CVS …
https://www.findhonestcare.com/blog-posts/is-zepbound-covere…
travel_explore
web search NEUTRAL — CVS Caremark’s decision to remove Zepbound from the CVS Caremark formulary, effective July 1, 2025, is not intended to reduce access to these medications, but rather to reasonably balance access and a…
https://www.mass.gov/news/cvs-caremark-decides-to-remove-zep…
travel_explore
web search NEUTRAL — CVS Caremark will resume covering the weight loss drug Zepbound this year after it removed it from its list of covered medications last year, drugmaker Eli Lilly said Thursday.
https://allaboutlawyer.com/cvs-caremark-zepbound-coverage-re…
help
Claim 6: “The country’s two other major PBMs — Express Scripts and Optum Rx — already cover Zepbound.”
INSUFFICIENT EVIDENCE
No evidence was gathered or provided to confirm or deny the coverage status of Zepbound at Express Scripts or Optum Rx.
check_circle
Claim 7: “Lilly said Thursday that Zepbound will return to CVS Caremark’s formulary by Oct. 1”
CORROBORATED
Multiple independent sources confirm Eli Lilly's statement that Zepbound will return to the CVS Caremark formulary by October 1.
travel_explore
web search NEUTRAL — CVS Caremark will add Eli Lilly's weight loss drug Zepbound back to its formulary by October 1, 2026, reversing a decision that cut off 25–30 million members from coverage last July.
https://allaboutlawyer.com/cvs-caremark-zepbound-coverage-re…
travel_explore
web search NEUTRAL — In 2025, CVS Caremark removed Zepbound from its main commercial drug lists and kept Wegovy as its preferred weight-loss option. On May 28, 2026, CVS announced Zepbound would return as an additional pr…
https://therxindex.com/guides/does-cvs-caremark-cover-zepbou…
travel_explore
web search NEUTRAL — Lilly said Thursday that Zepbound will return to CVS Caremark’s formulary by Oct. 1 and that some patients with private insurance could pay as little as a $25 copay. Foundayo, Lilly’s weight loss pill…
https://www.nbcnewyork.com/news/national-international/cvs-c…
check_circle
Claim 8: “A CVS Caremark spokesperson said the change applies to its standard formulary, affecting about 25 million to 30 million people.”
CORROBORATED
Multiple sources cite a CVS Caremark spokesperson stating the change affects the standard formulary, impacting 25 to 30 million people.
travel_explore
web search NEUTRAL — CVS Caremark's formulary decisions affect millions of people—but not everyone uniformlyCVS Caremark says the change was made to provide "wider access to effective weight management treatment" by stand…
https://www.findhonestcare.com/treatments/wegovy/insurance/c…
travel_explore
web search NEUTRAL — A CVS Caremark spokesperson said the change applies to its standard formulary, affecting about 25 million to 30 million people. Being added to the formulary does not guarantee the drugs will be covere…
https://www.nbcboston.com/news/national-international/cvs-ca…
travel_explore
web search NEUTRAL — About 25 to 30 million people are covered by the CVS Caremark standard formulary, and thousands on the formulary take a form of GLP-1 drug.
https://www.jconline.com/story/news/health/2026/05/28/cvs-ca…
info
Claim 9: “A class-action lawsuit challenging the decision was filed in September and remains active.”
SINGLE SOURCE
The web search results for 'class-action lawsuit' returned irrelevant results about Zoom classes and copyright organizations, providing no evidence of a lawsuit regarding Zepbound.
travel_explore
web search NEUTRAL — Class allows instructors to replicate an in-person classroom experience in an online environment. Built onZoom. Built forEducation. FOR TEACHERS Start a Zoom Class Start FOR TEACHERS & STUDENTS Join a…
https://main.web.global.prod.class.com/
travel_explore
web search NEUTRAL — Jun 16, 2025 · CLASS was established in 1999 by book publishers and authors to protect their published works. We are a government regulated non-profit organisation, seeking to eliminate unauthorised u…
https://class-singapore.com/
travel_explore
web search NEUTRAL — ClassDojo connects K-12 teachers with families. Free classroom communication, behavior tracking, and student portfolios. Used in 95% of US schools.
https://www.classdojo.com/
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.